Reducing the Volume of Single Use Plastic in Healthcare

In recent years we have all become more aware of the problems plastic causes to our environment and the need to massively reduce the amount of plastic waste we create.

Working with industry experts, the team at Shuttlepac identified the many pain points plaguing the healthcare industry with the use of conventional 95kPa biohazard bags. This included the enormous amount of plastic wastage. As a result, the reduction of plastic, as well as creating the highest quality product, is at the forefront of every single one of their designs.

The UN3373 compliant biohazard sample transport solution – the ShuttlePouch™ - is the best in show when it comes to reducing plastic wastage and providing secure secondary transport for biological material. Indeed, ShuttlePouch recently won an award for innovative packaging at the UK Packaging Awards. With up to 83% reduction in plastic material (average of 73% less across the range of standard biohazard bags), swapping to the ShuttlePouch™ has a noticeably positive environmental impact. This is especially true for the large number of home-test kits that are now in routine use.

With the effects of the pandemic still in full swing, it is estimated that the UK is currently testing over 4 million people per week. With this much single use plastic needing to be disposed of, and some of it incinerated, the only way to cut back on this is to make the plastic packaging as small as possible within the regulatory guidelines, which the majority of test providers aren’t currently doing.

Shuttlepac is the first in the industry to prioritise the reduction in plastic usage, and our overall environmental impact. Now is the time to move into the modern age by employing the state-of-the-art shuttlepac packaging solutions for biohazard transport.

Alpha Laboratories Ltd is the exclusive partner for Shuttlepac in the UK and Ireland.

More information online